More people are starting businesses out of opportunity than out of necessity; the percentage of immigrant entrepreneurs is at a two-decade high. However, new businesses are creating fewer jobs than they did a generation ago.
Johns Hopkins University President Ronald J. Daniels will co-chair the steering committee for a new statewide economic development strategy initiative focused on accelerating growth in the life sciences and cybersecurity industries in Maryland, Gov. Larry Hogan announced today.
Maryland’s governor is putting new economic development energy into creating life sciences and cybersecurity startups.
To kick off the Governor’s Business Summit in Baltimore this morning, Gov. Larry Hogan provided some details on Excel Maryland. It’s a new initiative that’s seeking to bring together government, university and the tech community to develop a new strategy to grow startups.
The complex life cycle of a biotechnology product, pharmaceutical or medical device demands a broad range of legal expertise across many practice specialties. From intellectual property protection to corporate and regulatory advice, the leading law firms in the life sciences space combine sophisticated legal counsel with deep scientific knowledge.
Partners HealthCare’s fund to advance innovations made at its hospitals has closed on the last $24.5 million of its most recent funding round.
Pharmaceutical giant Bayer has opened applications for its Grant4Apps programme. Geared to connect health start-ups with industry experts and help the best talents to thrive within the digital healthcare universe, the programme will offer start-ups an opportunity to become part of an economically inclusive market where innovation is not only encouraged but appreciated as a catalyst for expanding both economic and social growth, says Bayer.
We recently joined leaders from across the biomedical ecosystem at the White House to discuss how to best support biomedical innovation that improves human health and creates jobs and opportunity for economic growth. We discussed the unique role of National Institutes of Health-funded academic research in understanding the biology of human disease, and the irreplaceable role of the biotech industry in translating these basic science discoveries into breakthrough therapies for serious human diseases.
Biogen (NASDAQ: BIIB) announced today that it has completed an asset purchase of Remedy Pharmaceuticals’ Phase 3 candidate, CIRARA™ (intravenous glyburide). The target indication for CIRARA is large hemispheric infarction (LHI), a severe form of ischemic stroke where brain swelling (cerebral edema) often leads to a disproportionately large share of stroke-related morbidity and mortality. The U.S. Food and Drug Administration (FDA) recently granted CIRARA Orphan Drug Designation for severe cerebral edema in patients with acute ischemic stroke. The FDA has also granted CIRARA Fast Track designation.
Montgomery College is hosting a STEM Student Research Conference on its Germantown campus on Thursday, May 17, 2017, from 3:00-7:00 pm. The complete schedule is attached here, but I wanted to make you aware of the opportunity to hear Dr. Rebecca Goldin, our keynote speaker. Dr. Rebecca Goldin is a professor of mathematics at George Mason University and the Director of STATS, a program of Sense About Science USA aiming to support journalists’ quantitative and statistical understanding. Her one-hour presentation, which will be about the (mis)use of statistics in the media, begins at 3:00 pm, is free, and is open to the public. Please plan on joining us if your schedule will allow. – Margaret Latimer, VPP Germantown Campus, Collegwide STEM Unit
Conference Schedule:
Keynote Address 3 to 4 p.m., BE 151
Student Research Presentations ~ 4:15 to 5:15 p.m., BE Conference Center
Dinner, Awards Ceremony, and Panel Discussion ~ 5:30 p.m. to 7 p.m. RSVP required for dinner only: Tonya.Baker@montgomerycollege.edu
Keynote Address Statistics in the Media: Should You Believe Them? News accounts of science and scientific ideas are filled with numbers and implicit advice. They also tell a story. Do violent video games lead to violence? Does being overweight put one at risk for dementia? Can brain scans read our minds? Does chocolate make us smarter?
Smithers Avanza, a contract research organization supporting the pharmaceutical industry, announced that its Bioanalytical Services Division has completed the second expansion of its bioanalytical laboratory in the last two years. The expansion doubles the size of the Gaithersburg, Maryland lab, which now offers 15,000 square feet of space, and continues the trend of growth in support of client demand for services. Smithers Avanza plans to celebrate the completed expansion with clients, employees and community friends with an Open House.